Equities

Arch Therapeutics Inc

0HHJ:LSE

Arch Therapeutics Inc

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 06 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Sep 30 2023202320222021
ASSETS
Cash And Short Term Investments0.220.752.27
Total Receivables, Net------
Total Inventory1.361.411.09
Prepaid expenses0.360.440.31
Other current assets, total----0
Total current assets1.952.603.67
Property, plant & equipment, net0.000.000.01
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets0.000.000.00
Total assets1.962.603.68
LIABILITIES
Accounts payable2.301.330.41
Accrued expenses1.290.450.32
Notes payable/short-term debt000
Current portion long-term debt/capital leases5.630.550
Other current liabilities, total0.241.001.00
Total current liabilities9.473.321.73
Total long term debt02.811.60
Total debt5.633.361.60
Deferred income tax------
Minority interest------
Other liabilities, total00.661.37
Total liabilities9.476.804.70
SHAREHOLDERS EQUITY
Common stock0.000.250.24
Additional paid-in capital555149
Retained earnings (accumulated deficit)(62)(55)(50)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity(7.51)(4.19)(1.03)
Total liabilities & shareholders' equity1.962.603.68
Total common shares outstanding4.691.251.19
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.